Feasibility and Reliability of the Melbourne Assessment-2 (MA-2) for Telehealth
NCT ID: NCT06810063
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
35 participants
OBSERVATIONAL
2023-09-29
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Determine if a play based test of arm and hand movements is valid and reliable when conducted through telehealth for children with hemiplegic cerebral palsy.
2. Measure differences in parent, provider and child engagement when an assessment is conducted in-person compared to via telehealth.
3. Rate caregivers' overall impressions of procedures when an assessment is conducted in-person compared to telehealth.
Participants will attend two visits, one in person and one through telehealth. During each visit, the child will play with common toys. The sessions will be video recorded and scored using two standardized assessments, the Melbourne Assessment-2 (MA-2) and the Assisting Hand Assessment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Pediatric CIMT by Televideo
NCT05303883
IMPACT of an Instrumented Measurement on a Performance Assessment in Cerebral Palsy Treatment
NCT06565000
Pilot Study to Assess the Feasibility and Initial Efficacy of Therapist-as-consultant, Game-based CI Therapy
NCT03005457
Robotic-assisted Therapy to Improve Manual Dexterity in Children With Cerebral Palsy
NCT02923167
Contralaterally Controlled FES for Hand Opening in Hemiplegic Cerebral Palsy
NCT02925455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
In-person vs. telehealth assessment
Participants will be randomly assigned to in-person visit first or telehealth visit first. Both groups will complete both visits. Each visit requires about 20 minutes.
Assessment only, no intervention
Participants in this study complete two visits to test the agreement of telehealth and in person assessments of arm and hand movement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment only, no intervention
Participants in this study complete two visits to test the agreement of telehealth and in person assessments of arm and hand movement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hemiplegic cerebral palsy
* able to attend an in-person visit in the research lab OR live within 60 miles of the research lab
* able to attend a telehealth session with personal device
Exclusion Criteria
* unable to attend one in person visit and one telehealth visit within 1 month
2 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jill Heathcock
Professor, Division of Physical Therapy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jill Heathcock, PhD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023B0100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.